F&FFinancial Insights

Financial Metrics

VRTX VERTEX PHARMACEUTICALS INC / MA
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 398080000.0 USD 10-Q 2017-04-28
Quarterly 2016-06-30 431608000.0 +8.4% USD 10-Q 2017-07-28
Quarterly 2016-09-30 413783000.0 -4.1% USD 10-Q 2017-10-30
Quarterly 2017-03-31 714718000.0 +72.7% USD 10-Q 2018-04-27
Quarterly 2017-06-30 544135000.0 -23.9% USD 10-Q 2018-07-26
Quarterly 2017-09-30 578165000.0 +6.3% USD 10-Q 2018-10-25
Quarterly 2018-03-31 640799000.0 +10.8% USD 10-Q 2019-05-01
Quarterly 2018-06-30 752157000.0 +17.4% USD 10-Q 2019-08-01
Quarterly 2018-09-30 784535000.0 +4.3% USD 10-Q 2019-10-31
Quarterly 2019-03-31 858435000.0 +9.4% USD 10-Q 2020-05-01
Quarterly 2019-06-30 941293000.0 +9.7% USD 10-Q 2020-07-31
Quarterly 2019-09-30 949828000.0 +0.9% USD 10-Q 2020-10-30
Quarterly 2020-03-31 1515107000.0 +59.5% USD 10-Q 2021-04-30
Quarterly 2020-06-30 1524485000.0 +0.6% USD 10-Q 2021-07-30
Quarterly 2020-09-30 1538271000.0 +0.9% USD 10-Q 2021-11-03
Quarterly 2021-03-31 1724300000.0 +12.1% USD 10-Q 2022-05-06
Quarterly 2021-06-30 1793400000.0 +4.0% USD 10-Q 2022-08-05
Quarterly 2021-09-30 1984100000.0 +10.6% USD 10-Q 2022-10-28
Quarterly 2022-03-31 2097500000.0 +5.7% USD 10-Q 2023-05-02
Quarterly 2022-06-30 2196200000.0 +4.7% USD 10-Q 2023-08-02
Quarterly 2022-09-30 2334300000.0 +6.3% USD 10-Q 2023-11-07
Quarterly 2023-03-31 2374800000.0 +1.7% USD 10-Q 2024-05-07
Quarterly 2023-06-30 2493200000.0 +5.0% USD 10-Q 2024-08-02
Quarterly 2023-09-30 2483500000.0 -0.4% USD 10-Q 2024-11-05
Quarterly 2024-03-31 2690600000.0 +8.3% USD 10-Q 2025-05-06
Quarterly 2024-06-30 2645600000.0 -1.7% USD 10-Q 2025-08-05
Quarterly 2024-09-30 2771900000.0 +4.8% USD 10-Q 2025-11-04
Quarterly 2025-03-31 2770200000.0 -0.1% USD 10-Q 2025-05-06
Quarterly 2025-06-30 2964700000.0 +7.0% USD 10-Q 2025-08-05
Quarterly 2025-09-30 3076400000.0 +3.8% USD 10-Q 2025-11-04
Annual 2016-12-31 1702177000.0 USD 10-K 2019-02-13
Annual 2017-12-31 2488652000.0 +46.2% USD 10-K 2020-02-13
Annual 2018-12-31 3047597000.0 +22.5% USD 10-K 2021-02-11
Annual 2019-12-31 4162800000.0 +36.6% USD 10-K 2022-02-09
Annual 2020-12-31 6205700000.0 +49.1% USD 10-K 2023-02-10
Annual 2021-12-31 7574400000.0 +22.1% USD 10-K 2024-02-15
Annual 2022-12-31 8930700000.0 +17.9% USD 10-K 2025-02-13
Annual 2023-12-31 9869200000.0 +10.5% USD 10-K 2026-02-13
Annual 2024-12-31 11020100000.0 +11.7% USD 10-K 2026-02-13
Annual 2025-12-31 12001300000.0 +8.9% USD 10-K 2026-02-13

Gross Profit

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

Operating Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 -14330000.0 USD 10-Q 2017-04-28
Quarterly 2016-06-30 3353000.0 +123.4% USD 10-Q 2017-07-28
Quarterly 2016-09-30 -18727000.0 -658.5% USD 10-Q 2017-10-30
Quarterly 2017-03-31 270842000.0 +1546.3% USD 10-Q 2018-04-27
Quarterly 2017-06-30 52707000.0 -80.5% USD 10-Q 2018-07-26
Quarterly 2017-09-30 -326043000.0 -718.6% USD 10-Q 2018-10-25
Quarterly 2018-03-31 128901000.0 +139.5% USD 10-Q 2019-05-01
Quarterly 2018-06-30 172878000.0 +34.1% USD 10-Q 2019-08-01
Quarterly 2018-09-30 205649000.0 +19.0% USD 10-Q 2019-10-31
Quarterly 2019-03-31 276808000.0 +34.6% USD 10-Q 2020-05-01
Quarterly 2019-06-30 269960000.0 -2.5% USD 10-Q 2020-07-31
Quarterly 2019-09-30 99333000.0 -63.2% USD 10-Q 2020-10-30
Quarterly 2020-03-31 720224000.0 +625.1% USD 10-Q 2021-04-30
Quarterly 2020-06-30 718033000.0 -0.3% USD 10-Q 2021-07-30
Quarterly 2020-09-30 672241000.0 -6.4% USD 10-Q 2021-11-03
Quarterly 2021-03-31 887800000.0 +32.1% USD 10-Q 2022-05-06
Quarterly 2021-06-30 -37900000.0 -104.3% USD 10-Q 2022-08-05
Quarterly 2021-09-30 1054500000.0 +2882.3% USD 10-Q 2022-10-28
Quarterly 2022-03-31 1040900000.0 -1.3% USD 10-Q 2023-05-02
Quarterly 2022-06-30 1106300000.0 +6.3% USD 10-Q 2023-08-02
Quarterly 2022-09-30 1126700000.0 +1.8% USD 10-Q 2023-11-07
Quarterly 2023-03-31 779000000.0 -30.9% USD 10-Q 2024-05-07
Quarterly 2023-06-30 1026400000.0 +31.8% USD 10-Q 2024-08-02
Quarterly 2023-09-30 1038100000.0 +1.1% USD 10-Q 2024-11-05
Quarterly 2024-03-31 1139500000.0 +9.8% USD 10-Q 2025-05-06
Quarterly 2024-06-30 -3514700000.0 -408.4% USD 10-Q 2025-08-05
Quarterly 2024-09-30 1116300000.0 +131.8% USD 10-Q 2025-11-04
Quarterly 2025-03-31 630100000.0 -43.6% USD 10-Q 2025-05-06
Quarterly 2025-06-30 1151100000.0 +82.7% USD 10-Q 2025-08-05
Quarterly 2025-09-30 1186200000.0 +3.0% USD 10-Q 2025-11-04
Annual 2016-12-31 9936000.0 USD 10-K 2019-02-13
Annual 2017-12-31 123243000.0 +1140.4% USD 10-K 2020-02-13
Annual 2018-12-31 635150000.0 +415.4% USD 10-K 2021-02-11
Annual 2019-12-31 1197500000.0 +88.5% USD 10-K 2022-02-09
Annual 2020-12-31 2856300000.0 +138.5% USD 10-K 2023-02-10
Annual 2021-12-31 2782100000.0 -2.6% USD 10-K 2024-02-15
Annual 2022-12-31 4307400000.0 +54.8% USD 10-K 2025-02-13
Annual 2023-12-31 3832000000.0 -11.0% USD 10-K 2026-02-13
Annual 2024-12-31 -232900000.0 -106.1% USD 10-K 2026-02-13
Annual 2025-12-31 4173300000.0 +1891.9% USD 10-K 2026-02-13

Net Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 -36102000.0 USD 10-Q 2017-04-28
Quarterly 2016-06-30 -36151000.0 -0.1% USD 10-Q 2017-07-28
Quarterly 2016-09-30 -39537000.0 -9.4% USD 10-Q 2017-10-30
Quarterly 2017-03-31 249548000.0 +731.2% USD 10-Q 2018-04-27
Quarterly 2017-06-30 31169000.0 -87.5% USD 10-Q 2018-07-26
Quarterly 2017-09-30 -291267000.0 -1034.5% USD 10-Q 2018-10-25
Quarterly 2018-03-31 227301000.0 +178.0% USD 10-Q 2019-05-01
Quarterly 2018-06-30 206250000.0 -9.3% USD 10-Q 2019-08-01
Quarterly 2018-09-30 128456000.0 -37.7% USD 10-Q 2019-10-31
Quarterly 2019-03-31 268631000.0 +109.1% USD 10-Q 2020-05-01
Quarterly 2019-06-30 267427000.0 -0.4% USD 10-Q 2020-07-31
Quarterly 2019-09-30 57518000.0 -78.5% USD 10-Q 2020-10-30
Quarterly 2020-03-31 602753000.0 +947.9% USD 10-Q 2021-04-30
Quarterly 2020-06-30 837270000.0 +38.9% USD 10-Q 2021-07-30
Quarterly 2020-09-30 667434000.0 -20.3% USD 10-Q 2021-11-03
Quarterly 2021-03-31 653100000.0 -2.1% USD 10-Q 2022-05-06
Quarterly 2021-06-30 67000000.0 -89.7% USD 10-Q 2022-08-05
Quarterly 2021-09-30 851900000.0 +1171.5% USD 10-Q 2022-10-28
Quarterly 2022-03-31 762100000.0 -10.5% USD 10-Q 2023-05-02
Quarterly 2022-06-30 810500000.0 +6.4% USD 10-Q 2023-08-02
Quarterly 2022-09-30 930500000.0 +14.8% USD 10-Q 2023-11-07
Quarterly 2023-03-31 699800000.0 -24.8% USD 10-Q 2024-05-07
Quarterly 2023-06-30 915700000.0 +30.9% USD 10-Q 2024-08-02
Quarterly 2023-09-30 1035300000.0 +13.1% USD 10-Q 2024-11-05
Quarterly 2024-03-31 1099600000.0 +6.2% USD 10-Q 2025-05-06
Quarterly 2024-06-30 -3593600000.0 -426.8% USD 10-Q 2025-08-05
Quarterly 2024-09-30 1045400000.0 +129.1% USD 10-Q 2025-11-04
Quarterly 2025-03-31 646300000.0 -38.2% USD 10-Q 2025-05-06
Quarterly 2025-06-30 1032900000.0 +59.8% USD 10-Q 2025-08-05
Quarterly 2025-09-30 1082900000.0 +4.8% USD 10-Q 2025-11-04
Annual 2016-12-31 -84031000.0 USD 10-K 2019-02-13
Annual 2017-12-31 91635000.0 +209.0% USD 10-K 2020-02-13
Annual 2018-12-31 2087103000.0 +2177.6% USD 10-K 2021-02-11
Annual 2019-12-31 1176800000.0 -43.6% USD 10-K 2022-02-09
Annual 2020-12-31 2711700000.0 +130.4% USD 10-K 2023-02-10
Annual 2021-12-31 2342100000.0 -13.6% USD 10-K 2024-02-15
Annual 2022-12-31 3322000000.0 +41.8% USD 10-K 2025-02-13
Annual 2023-12-31 3619600000.0 +9.0% USD 10-K 2026-02-13
Annual 2024-12-31 -535600000.0 -114.8% USD 10-K 2026-02-13
Annual 2025-12-31 3953200000.0 +838.1% USD 10-K 2026-02-13

EPS Basic

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 -0.17 USD/shares 10-Q 2017-04-28
Quarterly 2016-06-30 -0.26 -52.9% USD/shares 10-Q 2017-07-28
Quarterly 2016-09-30 -0.16 +38.5% USD/shares 10-Q 2017-10-30
Quarterly 2017-03-31 1.01 +731.2% USD/shares 10-Q 2018-04-27
Quarterly 2017-06-30 0.07 -93.1% USD/shares 10-Q 2018-07-26
Quarterly 2017-09-30 -0.41 -685.7% USD/shares 10-Q 2018-10-25
Quarterly 2018-03-31 0.83 +302.4% USD/shares 10-Q 2019-05-01
Quarterly 2018-06-30 0.82 -1.2% USD/shares 10-Q 2019-08-01
Quarterly 2018-09-30 0.51 -37.8% USD/shares 10-Q 2019-10-31
Quarterly 2019-03-31 1.05 +105.9% USD/shares 10-Q 2020-05-01
Quarterly 2019-06-30 1.04 -1.0% USD/shares 10-Q 2020-07-31
Quarterly 2019-09-30 0.22 -78.8% USD/shares 10-Q 2020-10-30
Quarterly 2020-03-31 2.32 +954.5% USD/shares 10-Q 2021-04-30
Quarterly 2020-06-30 3.22 +38.8% USD/shares 10-Q 2021-07-30
Quarterly 2020-09-30 2.56 -20.5% USD/shares 10-Q 2021-11-03
Quarterly 2021-03-31 2.52 -1.6% USD/shares 10-Q 2022-05-06
Quarterly 2021-06-30 0.26 -89.7% USD/shares 10-Q 2022-08-05
Quarterly 2021-09-30 3.3 +1169.2% USD/shares 10-Q 2022-10-28
Quarterly 2022-03-31 2.99 -9.4% USD/shares 10-Q 2023-05-02
Quarterly 2022-06-30 3.17 +6.0% USD/shares 10-Q 2023-08-02
Quarterly 2022-09-30 3.63 +14.5% USD/shares 10-Q 2023-11-07
Quarterly 2023-03-31 2.72 -25.1% USD/shares 10-Q 2024-05-07
Quarterly 2023-06-30 3.55 +30.5% USD/shares 10-Q 2024-08-02
Quarterly 2023-09-30 4.01 +13.0% USD/shares 10-Q 2024-11-05
Quarterly 2024-03-31 4.26 +6.2% USD/shares 10-Q 2025-05-06
Quarterly 2024-06-30 -13.92 -426.8% USD/shares 10-Q 2025-08-05
Quarterly 2024-09-30 4.05 +129.1% USD/shares 10-Q 2025-11-04
Quarterly 2025-03-31 2.52 -37.8% USD/shares 10-Q 2025-05-06
Quarterly 2025-06-30 4.02 +59.5% USD/shares 10-Q 2025-08-05
Quarterly 2025-09-30 4.24 +5.5% USD/shares 10-Q 2025-11-04
Annual 2016-12-31 -0.46 USD/shares 10-K 2019-02-13
Annual 2017-12-31 1.06 +330.4% USD/shares 10-K 2020-02-13
Annual 2018-12-31 8.24 +677.4% USD/shares 10-K 2021-02-11
Annual 2019-12-31 4.58 -44.4% USD/shares 10-K 2022-02-09
Annual 2020-12-31 10.44 +127.9% USD/shares 10-K 2023-02-10
Annual 2021-12-31 9.09 -12.9% USD/shares 10-K 2024-02-15
Annual 2022-12-31 12.97 +42.7% USD/shares 10-K 2025-02-13
Annual 2023-12-31 14.05 +8.3% USD/shares 10-K 2026-02-13
Annual 2024-12-31 -2.08 -114.8% USD/shares 10-K 2026-02-13
Annual 2025-12-31 15.46 +843.3% USD/shares 10-K 2026-02-13

EPS Diluted

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 -0.17 USD/shares 10-Q 2017-04-28
Quarterly 2016-06-30 -0.26 -52.9% USD/shares 10-Q 2017-07-28
Quarterly 2016-09-30 -0.16 +38.5% USD/shares 10-Q 2017-10-30
Quarterly 2017-03-31 0.99 +718.7% USD/shares 10-Q 2018-04-27
Quarterly 2017-06-30 0.07 -92.9% USD/shares 10-Q 2018-07-26
Quarterly 2017-09-30 -0.41 -685.7% USD/shares 10-Q 2018-10-25
Quarterly 2018-03-31 0.81 +297.6% USD/shares 10-Q 2019-05-01
Quarterly 2018-06-30 0.8 -1.2% USD/shares 10-Q 2019-08-01
Quarterly 2018-09-30 0.5 -37.5% USD/shares 10-Q 2019-10-31
Quarterly 2019-03-31 1.03 +106.0% USD/shares 10-Q 2020-05-01
Quarterly 2019-06-30 1.03 +0.0% USD/shares 10-Q 2020-07-31
Quarterly 2019-09-30 0.22 -78.6% USD/shares 10-Q 2020-10-30
Quarterly 2020-03-31 2.29 +940.9% USD/shares 10-Q 2021-04-30
Quarterly 2020-06-30 3.18 +38.9% USD/shares 10-Q 2021-07-30
Quarterly 2020-09-30 2.53 -20.4% USD/shares 10-Q 2021-11-03
Quarterly 2021-03-31 2.49 -1.6% USD/shares 10-Q 2022-05-06
Quarterly 2021-06-30 0.26 -89.6% USD/shares 10-Q 2022-08-05
Quarterly 2021-09-30 3.28 +1161.5% USD/shares 10-Q 2022-10-28
Quarterly 2022-03-31 2.96 -9.8% USD/shares 10-Q 2023-05-02
Quarterly 2022-06-30 3.13 +5.7% USD/shares 10-Q 2023-08-02
Quarterly 2022-09-30 3.59 +14.7% USD/shares 10-Q 2023-11-07
Quarterly 2023-03-31 2.69 -25.1% USD/shares 10-Q 2024-05-07
Quarterly 2023-06-30 3.52 +30.9% USD/shares 10-Q 2024-08-02
Quarterly 2023-09-30 3.97 +12.8% USD/shares 10-Q 2024-11-05
Quarterly 2024-03-31 4.21 +6.0% USD/shares 10-Q 2025-05-06
Quarterly 2024-06-30 -13.92 -430.6% USD/shares 10-Q 2025-08-05
Quarterly 2024-09-30 4.01 +128.8% USD/shares 10-Q 2025-11-04
Quarterly 2025-03-31 2.49 -37.9% USD/shares 10-Q 2025-05-06
Quarterly 2025-06-30 3.99 +60.2% USD/shares 10-Q 2025-08-05
Quarterly 2025-09-30 4.2 +5.3% USD/shares 10-Q 2025-11-04
Annual 2016-12-31 -0.46 USD/shares 10-K 2019-02-13
Annual 2017-12-31 1.04 +326.1% USD/shares 10-K 2020-02-13
Annual 2018-12-31 8.09 +677.9% USD/shares 10-K 2021-02-11
Annual 2019-12-31 4.51 -44.3% USD/shares 10-K 2022-02-09
Annual 2020-12-31 10.29 +128.2% USD/shares 10-K 2023-02-10
Annual 2021-12-31 9.01 -12.4% USD/shares 10-K 2024-02-15
Annual 2022-12-31 12.82 +42.3% USD/shares 10-K 2025-02-13
Annual 2023-12-31 13.89 +8.3% USD/shares 10-K 2026-02-13
Annual 2024-12-31 -2.08 -115.0% USD/shares 10-K 2026-02-13
Annual 2025-12-31 15.32 +836.5% USD/shares 10-K 2026-02-13

8-K Material Event Details

42 filings · 71 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

759 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-04-01 Liu Joy EVP and Chief Legal Officer Open-market sell
S
Common Stock 978 $449.17 $439,288 21,833
2026-03-27 Bozic Carmen EVP and CMO Open-market sell
S
Common Stock 2,329 $450.95 $1,050,263 33,076
2026-03-13 Bozic Carmen EVP and CMO Open-market sell
S
Common Stock 2,329 $481.79 $1,122,089 35,405
2026-03-11 McKechnie Duncan EVP, Chief Commercial Officer Open-market sell
S
Common Stock 2,633 $498.42 $1,312,340 12,489
2026-03-04 McKechnie Duncan EVP, Chief Commercial Officer Open-market sell
S
Common Stock 2,437 $475.30 $1,158,306 15,122
2026-03-02 Liu Joy EVP and Chief Legal Officer Open-market sell
S
Common Stock 892 $495.96 $442,396 22,811
2026-02-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 1,725 $496.95 $857,239 98,278
2026-02-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 5,995 $496.16 $2,974,479 100,003
2026-02-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 15,580 $495.38 $7,718,020 105,998
2026-02-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 3,498 $494.33 $1,729,166 121,578
2026-02-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 2,520 $493.29 $1,243,091 125,076
2026-02-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 949 $491.30 $466,244 127,596
2026-02-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 2,725 $490.54 $1,336,722 128,545
2026-02-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 460 $489.32 $225,087 131,270
2026-02-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 3,278 $488.27 $1,600,549 131,730
2026-02-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 2,510 $487.13 $1,222,696 135,008
2026-02-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 240 $482.84 $115,882 137,518
2026-02-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 120 $481.50 $57,780 137,758
2026-02-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 400 $479.75 $191,900 137,878
2026-02-26 Ambrose Kristen SVP & Chief Accounting Officer Open-market sell
S
Common Stock 357 $483.36 $172,560 6,624
2026-02-24 WAGNER CHARLES F JR EVP, CO & FO Other disposed transaction
F
Common Stock 1,744 $485.11 $846,032 47,042
2026-02-19 Sachdev Amit EVP Chief Patient & Ext Af Off Exercise / conversion
M · derivative
Stock Option (Right to Buy) 25,026 $0.00 $0 0
2026-02-19 Sachdev Amit EVP Chief Patient & Ext Af Off Exercise / conversion
M · derivative
Stock Option (Right to Buy) 23,479 $0.00 $0 0
2026-02-19 Sachdev Amit EVP Chief Patient & Ext Af Off Open-market sell
S
Common Stock 4,237 $471.43 $1,997,449 58,934
2026-02-19 Sachdev Amit EVP Chief Patient & Ext Af Off Open-market sell
S
Common Stock 11,712 $470.54 $5,510,964 63,171
2026-02-19 Sachdev Amit EVP Chief Patient & Ext Af Off Open-market sell
S
Common Stock 7,241 $469.61 $3,400,446 74,883
2026-02-19 Sachdev Amit EVP Chief Patient & Ext Af Off Open-market sell
S
Common Stock 19,662 $468.57 $9,213,023 82,124
2026-02-19 Sachdev Amit EVP Chief Patient & Ext Af Off Open-market sell
S
Common Stock 10,263 $467.75 $4,800,518 101,786
2026-02-19 Sachdev Amit EVP Chief Patient & Ext Af Off Open-market sell
S
Common Stock 1,848 $465.80 $860,798 112,049
2026-02-19 Sachdev Amit EVP Chief Patient & Ext Af Off Open-market sell
S
Common Stock 2,730 $465.05 $1,269,586 113,897
2026-02-19 Sachdev Amit EVP Chief Patient & Ext Af Off Open-market sell
S
Common Stock 920 $463.91 $426,797 116,627
2026-02-19 Sachdev Amit EVP Chief Patient & Ext Af Off Exercise / conversion
M
Common Stock 25,026 $187.53 $4,693,126 117,547
2026-02-19 Sachdev Amit EVP Chief Patient & Ext Af Off Exercise / conversion
M
Common Stock 23,479 $155.57 $3,652,628 92,521
2026-02-17 WAGNER CHARLES F JR EVP, CO & FO Other disposed transaction
F
Common Stock 2,294 $483.75 $1,109,722 48,786
2026-02-17 WAGNER CHARLES F JR EVP, CO & FO Equity grant / award
A
Common Stock 7,365 $0.00 $0 51,080
2026-02-13 WAGNER CHARLES F JR EVP, CO & FO Other disposed transaction
F
Common Stock 4,565 $487.76 $2,226,624 43,715
2026-02-10 WAGNER CHARLES F JR EVP, CO & FO Other disposed transaction
F
Common Stock 3,045 $468.41 $1,426,308 48,280
2026-01-22 WAGNER CHARLES F JR EVP, CO & FO Equity grant / award
A
Common Stock 4,160 $0.00 $0 51,325
2026-01-22 WAGNER CHARLES F JR EVP, CO & FO Equity grant / award
A
Common Stock 9,440 $0.00 $0 47,165
2026-01-15 Upadhyay Suketu Dir Equity grant / award
A · derivative
Deferred Stock Units 80 $443.56 $35,625 2,719
2026-01-07 Tatsis Ourania EVP, Chief Reg. & Quality Off. Open-market sell
S
Common Stock 4,500 $474.99 $2,137,455 42,293
2026-01-06 WAGNER CHARLES F JR EVP, CO & FO Exercise / conversion
M · derivative
Stock Option (Right to Buy) 9,532 $0.00 $0 0
2026-01-06 WAGNER CHARLES F JR EVP, CO & FO Open-market sell
S
Common Stock 9,532 $461.00 $4,394,252 37,725
2026-01-06 WAGNER CHARLES F JR EVP, CO & FO Exercise / conversion
M
Common Stock 9,532 $189.38 $1,805,170 47,257
2025-12-03 WAGNER CHARLES F JR EVP, CO & FO Open-market sell
S
Common Stock 7,000 $461.00 $3,227,000 37,725
2025-11-19 CARNEY LLOYD Dir Equity grant / award
G
Common Stock 800 $0.00 $0 6,315
2025-11-17 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Open-market sell
S
Common Stock 2,500 $434.58 $1,086,450 16,852
2025-11-14 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M · derivative
Stock Option (Right to Buy) 39,769 $0.00 $0 63,781
2025-11-14 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M · derivative
Stock Option (Right to Buy) 13,835 $0.00 $0 1
2025-11-14 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 40 $442.00 $17,680 24,026
2025-11-14 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 21,330 $441.35 $9,413,996 24,066
2025-11-14 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 32,234 $440.30 $14,192,630 45,396
2025-11-14 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M
Common Stock 39,769 $86.52 $3,440,814 77,630
2025-11-14 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M
Common Stock 13,835 $91.05 $1,259,677 37,861
2025-11-13 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M · derivative
Stock Option (Right to Buy) 19,688 $0.00 $0 13,836
2025-11-13 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 1,160 $441.05 $511,618 24,026
2025-11-13 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 18,528 $440.22 $8,156,396 25,186
2025-11-13 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M
Common Stock 19,688 $91.05 $1,792,592 43,714
2025-10-15 Upadhyay Suketu Dir Equity grant / award
A · derivative
Deferred Stock Units 87 $410.31 $35,625 2,638
2025-10-02 Biller Jonathan EVP and Chief Legal Officer Open-market sell
S
Common Stock 694 $404.21 $280,522 15,653
2025-10-01 Biller Jonathan EVP and Chief Legal Officer Other disposed transaction
F
Common Stock 1,259 $400.00 $503,600 16,347
2025-08-27 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 266 $386.69 $102,860 4,565
2025-08-06 Kewalramani Reshma CEO & President Open-market buy
P
Common Stock 5,710 $389.95 $2,226,614 115,968
2025-08-06 Kewalramani Reshma CEO & President Open-market buy
P
Common Stock 4,290 $389.08 $1,669,153 110,258
2025-07-15 Upadhyay Suketu Dir Equity grant / award
A · derivative
Deferred Stock Units 76 $469.34 $35,625 2,552
2025-07-01 Arbuckle Stuart A EVP, COO Other disposed transaction
F
Common Stock 37,243 $450.23 $16,767,916 63,368
2025-05-15 ALTSHULER DAVID EVP, Chief Scientific Officer Open-market sell
S
Common Stock 52 $424.69 $22,084 23,281
2025-05-13 Arbuckle Stuart A EVP, COO Equity grant / award
A
Common Stock 37,622 $0.00 $0 100,611
2025-05-01 Upadhyay Suketu Dir Equity grant / award
A · derivative
Deferred Stock Units 1,001 2,476
2025-05-01 Upadhyay Suketu Dir Other disposed transaction
D
Common Stock 1,001 2,354
2025-05-01 Upadhyay Suketu Dir Equity grant / award
A
Common Stock 796 $0.00 $0 3,355
2025-04-15 Upadhyay Suketu Dir Equity grant / award
A · derivative
Deferred Stock Units 72 $497.51 $35,625 1,475
2025-03-13 ALTSHULER DAVID EVP, Chief Scientific Officer Open-market sell
S
Common Stock 3,231 $510.00 $1,647,810 23,281
2025-03-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 3,298 $500.00 $1,649,000 51,671
2025-03-04 Tatsis Ourania EVP, Chief Reg. & Quality Off. Open-market sell
S
Common Stock 4,058 $485.49 $1,970,118 54,481
2025-03-03 ALTSHULER DAVID EVP, Chief Scientific Officer Open-market sell
S
Common Stock 3,231 $490.00 $1,583,190 29,743
2025-02-26 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 4,962 $479.61 $2,379,825 54,969
2025-02-24 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 3,310 $483.28 $1,599,657 59,931
2025-02-20 ALTSHULER DAVID EVP, Chief Scientific Officer Open-market sell
S
Common Stock 1,111 $480.00 $533,280 45,019
2025-02-14 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 2,293 $463.46 $1,062,714 63,241
2025-02-12 WAGNER CHARLES F JR EVP & Chief Financial Officer Equity grant / award
A
Common Stock 6,655 $0.00 $0 65,534
2025-02-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 2,649 $467.98 $1,239,679 58,879
2025-02-04 WAGNER CHARLES F JR EVP & Chief Financial Officer Equity grant / award
A
Common Stock 7,114 $0.00 $0 61,528
2025-02-04 WAGNER CHARLES F JR EVP & Chief Financial Officer Equity grant / award
A
Common Stock 10,262 $0.00 $0 54,414
2025-01-15 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 112 $420.31 $46,929 15,145
2024-11-15 ALTSHULER DAVID EVP, Chief Scientific Officer Open-market sell
S
Common Stock 15 $478.56 $7,178 25,813
2024-11-11 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 3,000 $518.27 $1,554,810 44,137
2024-11-08 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 15,198 $515.00 $7,826,970 75,772
2024-10-15 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 90 $484.39 $43,750 15,033
2024-10-02 Biller Jonathan EVP and Chief Legal Officer Open-market sell
S
Common Stock 999 $461.66 $461,198 16,651
2024-10-01 Biller Jonathan EVP and Chief Legal Officer Other disposed transaction
F
Common Stock 630 $466.84 $294,109 17,650
2024-08-30 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 3,784 $499.00 $1,888,216 9,994
2024-08-08 Bhatia Sangeeta N. Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 1,292 $0.00 $0 646
2024-08-08 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 1,292 $466.29 $602,447 4,435
2024-08-08 Bhatia Sangeeta N. Dir Exercise / conversion
M
Common Stock 1,292 $152.74 $197,340 5,727
2024-08-07 Bozic Carmen EVP and CMO Open-market sell
S
Common Stock 2,280 $476.75 $1,086,990 23,259
2024-08-01 SACHS BRUCE I Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 5,295 $0.00 $0 0
2024-08-01 SACHS BRUCE I Dir Open-market sell
S
Common Stock 5,295 $508.00 $2,689,860 40,000
2024-08-01 SACHS BRUCE I Dir Exercise / conversion
M
Common Stock 5,295 $125.71 $665,634 45,295
2024-07-30 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 15,202 $505.00 $7,677,010 90,970
2024-07-24 Bozic Carmen EVP and CMO Open-market sell
S
Common Stock 2,280 $488.46 $1,113,689 25,539
2024-07-22 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 15,202 $497.00 $7,555,394 106,172
2024-07-15 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 89 $490.12 $43,750 14,943
2024-07-10 Bozic Carmen EVP and CMO Open-market sell
S
Common Stock 2,280 $487.34 $1,111,135 27,819
2024-06-26 Bozic Carmen EVP and CMO Open-market sell
S
Common Stock 2,280 $471.72 $1,075,522 30,099
2024-06-12 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Open-market sell
S
Common Stock 7,288 $478.00 $3,483,664 15,972
2024-06-12 Bozic Carmen EVP and CMO Open-market sell
S
Common Stock 2,280 $478.00 $1,089,840 32,379
2024-06-11 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Other disposed transaction
F
Common Stock 6,824 $481.96 $3,288,895 23,260
2024-06-05 Sachdev Amit EVP Chief Patient & Ext Af Off Equity grant / award
G
Common Stock 4,600 $0.00 $0 0
2024-06-03 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 3,250 $460.00 $1,495,000 47,137
2024-05-31 Tatsis Ourania EVP, Chief Reg. & Quality Off. Open-market sell
S
Common Stock 2,250 $445.00 $1,001,250 51,273
2024-05-30 Tatsis Ourania EVP, Chief Reg. & Quality Off. Open-market sell
S
Common Stock 2,350 $439.11 $1,031,908 53,523
2024-05-29 Bozic Carmen EVP and CMO Open-market sell
S
Common Stock 2,280 $445.56 $1,015,877 34,659
2024-05-28 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 3,250 $454.79 $1,478,068 50,387
2024-05-24 Kewalramani Reshma CEO & President Exercise / conversion
M · derivative
Stock Option (Right to Buy) 1,565 $0.00 $0 0
2024-05-24 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 1,565 $457.00 $715,205 121,374
2024-05-24 Kewalramani Reshma CEO & President Exercise / conversion
M
Common Stock 1,565 $187.53 $293,484 122,939
2024-05-22 SACHS BRUCE I Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 7,073 $0.00 $0 0
2024-05-22 SACHS BRUCE I Dir Open-market sell
S
Common Stock 7,073 $448.00 $3,168,704 40,000
2024-05-22 SACHS BRUCE I Dir Exercise / conversion
M
Common Stock 7,073 $93.51 $661,396 47,073
2024-05-20 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 15,202 $447.00 $6,795,294 121,374
2024-05-15 Sachdev Amit EVP Chief Patient & Ext Af Off Open-market sell
S
Common Stock 32 $430.93 $13,790 55,325
2024-05-14 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Equity grant / award
A
Common Stock 14,112 $0.00 $0 30,084
2024-05-01 Upadhyay Suketu Dir Equity grant / award
A · derivative
Deferred Stock Units 1,168 1,403
2024-05-01 Upadhyay Suketu Dir Other disposed transaction
D
Common Stock 1,168 2,559
2024-05-01 Upadhyay Suketu Dir Equity grant / award
A
Common Stock 1,001 $0.00 $0 3,727
2024-04-15 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 109 $399.58 $43,750 14,854
2024-04-02 Ambrose Kristen SVP & Chief Accounting Officer Open-market sell
S
Common Stock 240 $419.00 $100,560 7,500
2024-04-01 Ambrose Kristen SVP & Chief Accounting Officer Other disposed transaction
F
Common Stock 225 $418.10 $94,072 7,740
2024-02-23 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 3,309 $431.79 $1,428,793 53,583
2024-02-21 Tatsis Ourania EVP, Chief Reg. & Quality Off. Open-market sell
S
Common Stock 360 $421.77 $151,837 59,467
2024-02-20 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 2,812 $420.58 $1,182,671 56,892
2024-02-20 LEIDEN JEFFREY M Executive Chairman Other disposed transaction
F
Common Stock 4,118 $420.58 $1,731,948 13,778
2024-02-16 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 3,750 $424.01 $1,590,038 59,704
2024-02-15 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 4,655 $419.16 $1,951,190 17,896
2024-02-14 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 4,356 $419.04 $1,825,338 22,551
2024-02-13 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 737 $419.13 $308,899 26,907
2024-02-12 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 647 $420.39 $271,992 27,644
2024-02-12 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 2,009 $419.22 $842,213 28,291
2024-02-09 LEIDEN JEFFREY M Executive Chairman Other disposed transaction
F
Common Stock 8,048 $422.74 $3,402,212 30,300
2024-02-09 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 2,607 $422.74 $1,102,083 63,454
2024-02-08 LEIDEN JEFFREY M Executive Chairman Other disposed transaction
F
Common Stock 2,698 $421.73 $1,137,828 38,348
2024-02-07 WAGNER CHARLES F JR EVP & Chief Financial Officer Equity grant / award
A
Common Stock 7,114 $0.00 $0 66,061
2024-02-06 WAGNER CHARLES F JR EVP & Chief Financial Officer Equity grant / award
A
Common Stock 9,440 $0.00 $0 58,947
2024-02-06 WAGNER CHARLES F JR EVP & Chief Financial Officer Equity grant / award
A
Common Stock 5,814 $0.00 $0 49,507
2024-01-12 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 101 $432.99 $43,750 14,744
2024-01-08 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 6,648 $419.07 $2,785,977 2,423
2024-01-02 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 3,000 $405.00 $1,215,000 43,693
2023-12-15 Kewalramani Reshma CEO & President Exercise / conversion
M · derivative
Stock Option (Right to Buy) 14,077 $0.00 $0 1,565
2023-12-15 Kewalramani Reshma CEO & President Exercise / conversion
M · derivative
Stock Option (Right to Buy) 3,058 $0.00 $0 0
2023-12-15 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 17,135 $407.00 $6,973,945 108,711
2023-12-15 Kewalramani Reshma CEO & President Exercise / conversion
M
Common Stock 14,077 $187.53 $2,639,860 125,846
2023-12-15 Kewalramani Reshma CEO & President Exercise / conversion
M
Common Stock 3,058 $155.57 $475,733 111,769
2023-12-13 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 100 $400.19 $40,019 9,071
2023-12-13 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 13,254 $399.41 $5,293,780 9,171
2023-12-05 Thornberry Nancy Dir Equity grant / award
A
Common Stock 1,136 $0.00 $0 1,136
2023-11-20 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 3,000 $349.88 $1,049,640 46,693
2023-11-15 Sachdev Amit EVP Chief Patient & Ext Af Off Open-market sell
S
Common Stock 35 $369.92 $12,947 58,814
2023-11-14 Bozic Carmen EVP and CMO Open-market sell
S
Common Stock 5,650 $380.82 $2,151,633 29,302
2023-11-13 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 5,097 $377.00 $1,921,569 113,809
2023-11-06 SACHS BRUCE I Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 11,250 $0.00 $0 11,250
2023-11-06 SACHS BRUCE I Dir Open-market sell
S
Common Stock 11,250 $385.00 $4,331,250 40,000
2023-11-06 SACHS BRUCE I Dir Exercise / conversion
M
Common Stock 11,250 $127.54 $1,434,825 51,250
2023-10-31 Bozic Carmen EVP and CMO Open-market sell
S
Common Stock 5,651 $355.92 $2,011,304 34,952
2023-10-17 Bozic Carmen EVP and CMO Open-market sell
S
Common Stock 5,651 $373.25 $2,109,236 40,603
2023-10-16 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 12,962 $374.00 $4,847,788 22,425
2023-10-13 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 118 $369.98 $43,750 14,643
2023-10-06 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 242 $360.00 $87,120 4,144
2023-10-05 Lagarde Michel Dir Equity grant / award
A
Common Stock 1,132 $0.00 $0 1,132
2023-10-03 Bozic Carmen EVP and CMO Open-market sell
S
Common Stock 5,651 $345.28 $1,951,177 46,254
2023-10-02 Biller Jonathan EVP and Chief Legal Officer Open-market sell
S
Common Stock 610 $346.76 $211,524 10,569
2023-09-29 Biller Jonathan EVP and Chief Legal Officer Other disposed transaction
F
Common Stock 408 $350.72 $143,094 11,179
2023-09-19 Bozic Carmen EVP and CMO Open-market sell
S
Common Stock 5,651 $351.00 $1,983,501 51,905
2023-09-05 Bozic Carmen EVP and CMO Open-market sell
S
Common Stock 5,651 $352.66 $1,992,882 57,556
2023-08-23 Tatsis Ourania EVP, Chief Reg. & Quality Off. Open-market sell
S
Common Stock 2,500 $355.00 $887,500 48,637
2023-08-10 Kearney Terrence C Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 10,000 $0.00 $0 10,000
2023-08-10 Kearney Terrence C Dir Open-market sell
S
Common Stock 10,000 $350.00 $3,500,000 6,536
2023-08-10 Kearney Terrence C Dir Exercise / conversion
M
Common Stock 10,000 $127.54 $1,275,400 16,536
2023-08-09 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 63 $345.51 $21,767 32,038
2023-07-17 SACHS BRUCE I Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 11,250 $0.00 $0 11,250
2023-07-17 SACHS BRUCE I Dir Open-market sell
S
Common Stock 3,842 $357.29 $1,372,708 40,000
2023-07-17 SACHS BRUCE I Dir Open-market sell
S
Common Stock 5,711 $356.75 $2,037,399 43,842
2023-07-17 SACHS BRUCE I Dir Open-market sell
S
Common Stock 1,697 $355.54 $603,351 49,553
2023-07-17 SACHS BRUCE I Dir Exercise / conversion
M
Common Stock 11,250 $127.54 $1,434,825 51,250
2023-07-17 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 7,828 $355.00 $2,778,940 118,906
2023-07-14 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 125 $350.79 $43,750 14,525
2023-06-15 Arbuckle Stuart A EVP, COO Exercise / conversion
M · derivative
Stock Option (Right to Buy) 8,603 $0.00 $0 8,603
2023-06-15 Arbuckle Stuart A EVP, COO Open-market sell
S
Common Stock 8,603 $349.00 $3,002,447 56,556
2023-06-15 Arbuckle Stuart A EVP, COO Exercise / conversion
M
Common Stock 8,603 $187.53 $1,613,321 65,159
2023-05-30 Arbuckle Stuart A EVP, COO Open-market sell
S
Common Stock 82 $329.82 $27,045 56,556
2023-05-08 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 2,850 $350.00 $997,500 32,038
2023-05-05 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 422 $350.03 $147,713 34,888
2023-05-03 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 728 $351.60 $255,965 35,310
2023-05-03 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 2,053 $350.44 $719,453 36,038
2023-05-02 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 169 $353.24 $59,698 38,091
2023-05-02 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 42 $351.65 $14,769 38,260
2023-05-02 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 1,411 $350.32 $494,302 38,302
2023-05-01 Upadhyay Suketu Dir Equity grant / award
A
Common Stock 1,168 $0.00 $0 2,726
2023-04-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 38 $340.19 $12,927 126,652
2023-04-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 1,668 $339.43 $566,169 126,690
2023-04-27 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 1,611 $338.69 $545,630 128,358
2023-04-14 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 131 $332.77 $43,750 14,400
2023-04-12 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 2,625 $327.43 $859,504 39,713
2023-04-12 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 4,068 $326.45 $1,327,999 42,338
2023-04-12 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 874 $325.70 $284,662 46,406
2023-04-04 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 31 $318.68 $9,879 47,280
2023-04-04 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 96 $317.65 $30,494 47,311
2023-04-04 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 90 $316.76 $28,508 47,407
2023-04-04 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 94 $315.66 $29,672 47,497
2023-04-04 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 211 $314.22 $66,300 47,591
2023-03-31 Sanna Bastiano EVP, Cell & Genetic Therapies Other disposed transaction
F
Common Stock 1,466 $313.74 $459,943 47,802
2023-03-24 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 1,768 $305.38 $539,912 49,611
2023-03-17 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 16 $301.13 $4,818 51,379
2023-03-17 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 240 $299.58 $71,899 51,395
2023-03-17 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 784 $295.43 $231,617 52,235
2023-03-17 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 360 $298.09 $107,312 51,635
2023-03-16 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 264 $301.07 $79,482 49,268
2023-03-16 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 2,482 $300.54 $745,940 49,532
2023-03-13 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 62 $296.77 $18,400 53,379
2023-03-13 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 292 $295.89 $86,400 53,441
2023-03-13 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 715 $294.52 $210,582 53,733
2023-03-13 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 1,153 $293.35 $338,233 54,448
2023-03-13 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 420 $292.41 $122,812 55,061
2023-03-13 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 24 $288.31 $6,919 56,021
2023-03-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 102 $294.94 $30,084 56,045
2023-03-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 27 $293.61 $7,927 56,147
2023-03-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 185 $292.68 $54,146 56,174
2023-03-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 541 $291.47 $157,685 56,359
2023-03-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 30 $289.44 $8,683 56,900
2023-03-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 327 $288.91 $94,474 56,930
2023-03-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 515 $287.83 $148,232 57,257
2023-03-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 361 $286.64 $103,477 57,772
2023-02-24 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 3,308 $289.12 $956,409 58,133
2023-02-22 Arbuckle Stuart A EVP, COO Open-market sell
S
Common Stock 200 $296.31 $59,262 66,304
2023-02-22 Arbuckle Stuart A EVP, COO Open-market sell
S
Common Stock 394 $295.38 $116,380 66,504
2023-02-22 Arbuckle Stuart A EVP, COO Open-market sell
S
Common Stock 1,378 $294.29 $405,532 66,898
2023-02-22 Arbuckle Stuart A EVP, COO Open-market sell
S
Common Stock 300 $292.86 $87,858 68,276
2023-02-22 Arbuckle Stuart A EVP, COO Open-market sell
S
Common Stock 129 $291.84 $37,647 68,576
2023-02-17 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 3,750 $292.85 $1,098,188 61,441
2023-02-14 Tatsis Ourania EVP, Chief Reg. & Quality Off. Open-market sell
S
Common Stock 51 $300.58 $15,330 65,445
2023-02-14 Tatsis Ourania EVP, Chief Reg. & Quality Off. Open-market sell
S
Common Stock 135 $299.60 $40,446 65,496
2023-02-14 Tatsis Ourania EVP, Chief Reg. & Quality Off. Open-market sell
S
Common Stock 43 $297.98 $12,813 65,631
2023-02-14 Tatsis Ourania EVP, Chief Reg. & Quality Off. Open-market sell
S
Common Stock 20 $296.48 $5,930 65,674
2023-02-14 Tatsis Ourania EVP, Chief Reg. & Quality Off. Open-market sell
S
Common Stock 71 $295.89 $21,008 65,694
2023-02-13 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 4,992 $298.26 $1,488,914 65,191
2023-02-13 LEIDEN JEFFREY M Executive Chairman Other disposed transaction
F
Common Stock 13,344 $298.26 $3,979,981 62,079
2023-02-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 2,707 $294.33 $796,751 70,183
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Exercise / conversion
M · derivative
Stock Option (Right to Buy) 1,304 $0.00 $0 0
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 153 $309.06 $47,286 68,645
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 620 $306.70 $190,154 68,798
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 349 $305.08 $106,473 69,418
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 100 $303.64 $30,364 69,767
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 70 $302.00 $21,140 69,867
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 12 $300.39 $3,605 69,937
2023-02-06 ALTSHULER DAVID EVP, Global Research and CSO Exercise / conversion
M
Common Stock 1,304 $187.53 $244,539 69,949
2023-02-01 WAGNER CHARLES F JR EVP & Chief Financial Officer Equity grant / award
A
Common Stock 9,440 $0.00 $0 72,890
2023-02-01 WAGNER CHARLES F JR EVP & Chief Financial Officer Equity grant / award
A
Common Stock 10,262 $0.00 $0 63,450
2023-02-01 WAGNER CHARLES F JR EVP & Chief Financial Officer Equity grant / award
A
Common Stock 10,324 $0.00 $0 53,188
2023-01-31 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 106 $325.00 $34,450 37,998
2023-01-30 CARNEY LLOYD Dir Open-market sell
S
Common Stock 324 $321.84 $104,276 4,150
2023-01-30 CARNEY LLOYD Dir Open-market sell
S
Common Stock 1,000 $320.70 $320,700 4,474
2023-01-30 CARNEY LLOYD Dir Open-market sell
S
Common Stock 1,376 $320.08 $440,430 5,474
2023-01-27 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 1,429 $0.00 $0 0
2023-01-27 Lee Yuchun Dir Open-market sell
S
Common Stock 80 $323.33 $25,866 1,875
2023-01-27 Lee Yuchun Dir Open-market sell
S
Common Stock 970 $322.20 $312,534 1,955
2023-01-27 Lee Yuchun Dir Open-market sell
S
Common Stock 379 $321.31 $121,776 2,925
2023-01-27 Lee Yuchun Dir Exercise / conversion
M
Common Stock 1,429 $72.14 $103,088 3,304
2023-01-26 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 4,000 $0.00 $0 1,429
2023-01-26 Lee Yuchun Dir Open-market sell
S
Common Stock 680 $320.94 $218,239 1,875
2023-01-26 Lee Yuchun Dir Open-market sell
S
Common Stock 400 $320.25 $128,100 2,555
2023-01-26 Lee Yuchun Dir Open-market sell
S
Common Stock 478 $319.25 $152,602 2,955
2023-01-26 Lee Yuchun Dir Open-market sell
S
Common Stock 1,000 $317.95 $317,950 3,433
2023-01-26 Lee Yuchun Dir Open-market sell
S
Common Stock 1,140 $316.82 $361,175 4,433
2023-01-26 Lee Yuchun Dir Open-market sell
S
Common Stock 302 $315.42 $95,257 5,573
2023-01-26 Lee Yuchun Dir Exercise / conversion
M
Common Stock 4,000 $72.14 $288,560 5,875
2023-01-25 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 4,000 $0.00 $0 5,429
2023-01-25 Lee Yuchun Dir Open-market sell
S
Common Stock 579 $314.95 $182,356 1,875
2023-01-25 Lee Yuchun Dir Open-market sell
S
Common Stock 2,621 $314.10 $823,256 2,454
2023-01-25 Lee Yuchun Dir Open-market sell
S
Common Stock 800 $312.80 $250,240 5,075
2023-01-25 Lee Yuchun Dir Exercise / conversion
M
Common Stock 4,000 $72.14 $288,560 5,875
2023-01-24 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 4,000 $0.00 $0 9,429
2023-01-24 Lee Yuchun Dir Open-market sell
S
Common Stock 1,489 $313.36 $466,593 1,875
2023-01-24 Lee Yuchun Dir Open-market sell
S
Common Stock 2,511 $312.29 $784,160 3,364
2023-01-24 Lee Yuchun Dir Exercise / conversion
M
Common Stock 4,000 $72.14 $288,560 5,875
2023-01-23 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,129 $0.00 $0 13,429
2023-01-23 Lee Yuchun Dir Open-market sell
S
Common Stock 2,129 $312.02 $664,291 1,875
2023-01-23 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,129 $72.14 $153,586 4,004
2023-01-18 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 442 $0.00 $0 15,558
2023-01-18 Lee Yuchun Dir Open-market sell
S
Common Stock 442 $312.17 $137,979 1,875
2023-01-18 Lee Yuchun Dir Exercise / conversion
M
Common Stock 442 $72.14 $31,886 2,317
2023-01-17 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 4,000 $0.00 $0 16,000
2023-01-17 Lee Yuchun Dir Open-market sell
S
Common Stock 4,000 $312.03 $1,248,120 1,875
2023-01-17 Lee Yuchun Dir Exercise / conversion
M
Common Stock 4,000 $72.14 $288,560 5,875
2023-01-13 Upadhyay Suketu Dir Equity grant / award
A · derivative
Deferred Stock Units 96 $298.42 $28,750 235
2022-12-06 Arbuckle Stuart A EVP, COO Equity grant / award
A
Common Stock 12,753 $0.00 $0 58,031
2022-11-15 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 34 $308.61 $10,493 36,077
2022-11-07 ALTSHULER DAVID EVP, Global Research and CSO Exercise / conversion
M · derivative
Stock Option (Right to Buy) 1,303 $0.00 $0 1,304
2022-11-07 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 83 $306.57 $25,445 36,077
2022-11-07 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 280 $304.58 $85,282 36,300
2022-11-07 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 261 $303.21 $79,138 36,580
2022-11-07 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 189 $301.99 $57,076 36,841
2022-11-07 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 210 $300.96 $63,202 37,030
2022-11-07 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 140 $305.39 $42,755 36,160
2022-11-07 ALTSHULER DAVID EVP, Global Research and CSO Exercise / conversion
M
Common Stock 1,303 $187.53 $244,352 37,380
2022-11-02 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 22 $317.77 $6,991 38,104
2022-11-02 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 10 $315.68 $3,157 38,126
2022-11-02 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 12 $314.43 $3,773 38,136
2022-11-02 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 81 $313.37 $25,383 38,148
2022-11-02 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 100 $312.40 $31,240 38,229
2022-11-02 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 39 $311.17 $12,136 38,329
2022-11-02 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 56 $310.10 $17,366 38,368
2022-11-01 Sanna Bastiano EVP, Cell & Genetic Therapies Other disposed transaction
F
Common Stock 768 $312.84 $240,261 38,424
2022-10-24 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 621 $310.00 $192,510 4,040
2022-10-18 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 288 $301.84 $86,930 39,192
2022-10-18 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 1,503 $300.02 $450,930 39,480
2022-10-14 Upadhyay Suketu Dir Equity grant / award
A · derivative
Deferred Stock Units 97 $296.82 $28,750 139
2022-09-19 Biller Jonathan EVP and Chief Legal Officer Equity grant / award
A
Common Stock 5,294 $0.00 $0 5,294
2022-08-15 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 11,689 $305.06 $3,565,846 99,598
2022-08-10 Arbuckle Stuart A EVP, COO Exercise / conversion
M · derivative
Stock Option (Right to Buy) 64 $0.00 $0 6,571
2022-08-10 Arbuckle Stuart A EVP, COO Open-market sell
S
Common Stock 9 $302.01 $2,718 60,880
2022-08-10 Arbuckle Stuart A EVP, COO Open-market sell
S
Common Stock 171 $300.32 $51,355 60,889
2022-08-10 Arbuckle Stuart A EVP, COO Exercise / conversion
M
Common Stock 64 $155.57 $9,956 61,060
2022-08-09 Liu Joy SVP, General Counsel Open-market sell
S
Common Stock 946 $300.00 $283,800 13,388
2022-08-08 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 47 $295.53 $13,890 4,661
2022-08-08 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 161 $294.24 $47,373 4,708
2022-08-08 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 204 $293.15 $59,803 4,869
2022-08-08 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 164 $291.76 $47,849 5,073
2022-08-08 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 45 $290.18 $13,058 5,237
2022-08-01 Sanna Bastiano EVP, Cell & Genetic Therapies Other disposed transaction
F
Common Stock 766 $276.62 $211,891 40,983
2022-07-29 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 5 $282.34 $1,412 5,282
2022-07-29 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 58 $281.03 $16,300 5,287
2022-07-29 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 160 $279.28 $44,685 5,444
2022-07-29 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 200 $277.95 $55,590 5,604
2022-07-29 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 99 $280.22 $27,742 5,345
2022-07-25 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M · derivative
Stock Option (Right to Buy) 60,342 $0.00 $0 33,524
2022-07-25 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 10,471 $283.42 $2,967,691 2,423
2022-07-25 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 40,666 $282.43 $11,485,298 12,894
2022-07-25 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 34,090 $281.27 $9,588,494 53,560
2022-07-25 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 32,983 $280.37 $9,247,444 87,650
2022-07-25 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 13,869 $279.44 $3,875,553 120,633
2022-07-25 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M
Common Stock 60,342 $91.05 $5,494,139 134,502
2022-07-19 ALTSHULER DAVID EVP, Global Research and CSO Exercise / conversion
M · derivative
Stock Option (Right to Buy) 7,338 $0.00 $0 0
2022-07-19 ALTSHULER DAVID EVP, Global Research and CSO Exercise / conversion
M · derivative
Stock Option (Right to Buy) 10,427 $0.00 $0 3,911
2022-07-19 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 6,604 $289.48 $1,911,726 36,077
2022-07-19 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 5,737 $288.67 $1,656,100 42,681
2022-07-19 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 4,561 $287.83 $1,312,793 48,418
2022-07-19 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 963 $286.72 $276,111 52,979
2022-07-19 ALTSHULER DAVID EVP, Global Research and CSO Exercise / conversion
M
Common Stock 7,338 $155.57 $1,141,573 53,942
2022-07-19 ALTSHULER DAVID EVP, Global Research and CSO Exercise / conversion
M
Common Stock 10,427 $187.53 $1,955,375 46,604
2022-07-15 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 151 $289.23 $43,750 13,975
2022-06-24 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 11,689 $291.30 $3,405,006 111,153
2022-05-31 Bozic Carmen EVP and CMO Other disposed transaction
F
Common Stock 311 $271.24 $84,356 49,512
2022-05-18 Upadhyay Suketu Dir Equity grant / award
A
Common Stock 1,558 $0.00 $0 1,558
2022-05-16 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 15 $253.99 $3,810 41,757
2022-05-16 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 8 $254.44 $2,036 41,749
2022-05-16 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 7 $252.43 $1,767 41,772
2022-05-04 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 36 $275.09 $9,903 41,660
2022-05-02 Arbuckle Stuart A EVP, COO Open-market sell
S
Common Stock 306 $263.98 $80,778 64,760
2022-05-01 Kearney Terrence C Dir Equity grant / award
A · derivative
Stock Option (Right to Buy) 2,231 $0.00 $0 2,231
2022-05-01 Kearney Terrence C Dir Equity grant / award
A
Common Stock 725 $0.00 $0 6,536
2022-04-29 Liu Joy SVP, General Counsel Open-market sell
S
Common Stock 10 $278.04 $2,780 14,334
2022-04-29 Liu Joy SVP, General Counsel Open-market sell
S
Common Stock 22 $276.72 $6,088 14,344
2022-04-29 Liu Joy SVP, General Counsel Open-market sell
S
Common Stock 30 $275.62 $8,269 14,366
2022-04-29 Liu Joy SVP, General Counsel Open-market sell
S
Common Stock 41 $274.75 $11,265 14,396
2022-04-29 Liu Joy SVP, General Counsel Open-market sell
S
Common Stock 17 $273.37 $4,647 14,437
2022-04-25 Ambrose Kristen SVP & Chief Accounting Officer Open-market sell
S
Common Stock 104 $271.68 $28,255 3,496
2022-04-25 Ambrose Kristen SVP & Chief Accounting Officer Open-market sell
S
Common Stock 83 $269.51 $22,369 3,600
2022-04-25 Ambrose Kristen SVP & Chief Accounting Officer Open-market sell
S
Common Stock 80 $268.46 $21,477 3,683
2022-04-25 Ambrose Kristen SVP & Chief Accounting Officer Open-market sell
S
Common Stock 60 $267.37 $16,042 3,763
2022-04-18 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 0
2022-04-18 Lee Yuchun Dir Open-market sell
S
Common Stock 119 $286.80 $34,129 1,875
2022-04-18 Lee Yuchun Dir Open-market sell
S
Common Stock 491 $285.16 $140,014 1,994
2022-04-18 Lee Yuchun Dir Open-market sell
S
Common Stock 1,008 $284.06 $286,332 2,485
2022-04-18 Lee Yuchun Dir Open-market sell
S
Common Stock 382 $282.70 $107,991 3,493
2022-04-18 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $81.54 $163,080 3,875
2022-04-14 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 2,000
2022-04-14 Lee Yuchun Dir Open-market sell
S
Common Stock 400 $291.18 $116,472 1,875
2022-04-14 Lee Yuchun Dir Open-market sell
S
Common Stock 252 $288.92 $72,808 2,675
2022-04-14 Lee Yuchun Dir Open-market sell
S
Common Stock 948 $287.87 $272,901 2,927
2022-04-14 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $81.54 $163,080 3,875
2022-04-13 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 4,000
2022-04-13 Lee Yuchun Dir Open-market sell
S
Common Stock 354 $291.12 $103,056 1,875
2022-04-13 Lee Yuchun Dir Open-market sell
S
Common Stock 400 $288.55 $115,420 2,429
2022-04-13 Lee Yuchun Dir Open-market sell
S
Common Stock 200 $290.17 $58,034 2,229
2022-04-13 Lee Yuchun Dir Open-market sell
S
Common Stock 228 $284.90 $64,957 3,329
2022-04-13 Lee Yuchun Dir Open-market sell
S
Common Stock 300 $286.24 $85,872 3,029
2022-04-13 Lee Yuchun Dir Open-market sell
S
Common Stock 18 $281.49 $5,067 3,857
2022-04-13 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $81.54 $163,080 3,875
2022-04-13 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 15,789 $289.04 $4,563,653 74,160
2022-04-12 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 6,000
2022-04-12 Lee Yuchun Dir Open-market sell
S
Common Stock 300 $283.15 $84,945 1,875
2022-04-12 Lee Yuchun Dir Open-market sell
S
Common Stock 318 $281.70 $89,581 2,175
2022-04-12 Lee Yuchun Dir Open-market sell
S
Common Stock 1,182 $280.61 $331,681 2,493
2022-04-12 Lee Yuchun Dir Open-market sell
S
Common Stock 200 $279.22 $55,844 3,675
2022-04-12 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $81.54 $163,080 3,875
2022-04-11 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 8,000
2022-04-11 Lee Yuchun Dir Open-market sell
S
Common Stock 110 $281.58 $30,974 1,875
2022-04-11 Lee Yuchun Dir Open-market sell
S
Common Stock 968 $280.62 $271,640 1,985
2022-04-11 Lee Yuchun Dir Open-market sell
S
Common Stock 922 $279.81 $257,985 2,953
2022-04-11 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $81.54 $163,080 3,875
2022-04-08 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 10,000
2022-04-08 Lee Yuchun Dir Open-market sell
S
Common Stock 452 $280.37 $126,727 1,875
2022-04-08 Lee Yuchun Dir Open-market sell
S
Common Stock 700 $279.36 $195,552 2,327
2022-04-08 Lee Yuchun Dir Open-market sell
S
Common Stock 430 $277.29 $119,235 3,027
2022-04-08 Lee Yuchun Dir Open-market sell
S
Common Stock 418 $276.62 $115,627 3,457
2022-04-08 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $81.54 $163,080 3,875
2022-04-07 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 12,000
2022-04-07 Lee Yuchun Dir Open-market sell
S
Common Stock 100 $277.02 $27,702 1,875
2022-04-07 Lee Yuchun Dir Open-market sell
S
Common Stock 727 $276.37 $200,921 1,975
2022-04-07 Lee Yuchun Dir Open-market sell
S
Common Stock 256 $275.26 $70,467 2,702
2022-04-07 Lee Yuchun Dir Open-market sell
S
Common Stock 500 $273.78 $136,890 2,958
2022-04-07 Lee Yuchun Dir Open-market sell
S
Common Stock 417 $272.76 $113,741 3,458
2022-04-07 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $81.54 $163,080 3,875
2022-04-07 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 30 $277.02 $8,311 42,782
2022-04-07 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 327 $276.39 $90,380 42,812
2022-04-07 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 204 $275.71 $56,245 43,139
2022-04-06 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 14,000
2022-04-06 Lee Yuchun Dir Open-market sell
S
Common Stock 83 $272.84 $22,646 1,875
2022-04-06 Lee Yuchun Dir Open-market sell
S
Common Stock 1,600 $271.78 $434,848 1,958
2022-04-06 Lee Yuchun Dir Open-market sell
S
Common Stock 300 $270.67 $81,201 3,558
2022-04-06 Lee Yuchun Dir Open-market sell
S
Common Stock 17 $267.57 $4,549 3,858
2022-04-06 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $81.54 $163,080 3,875
2022-04-05 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 3,163 $275.23 $870,552 43,343
2022-04-04 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 257 $268.43 $68,987 46,506
2022-04-04 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 305 $267.10 $81,466 46,763
2022-04-01 Ambrose Kristen SVP & Chief Accounting Officer Other disposed transaction
F
Common Stock 137 $263.09 $36,043 3,823
2022-03-31 MCGLYNN MARGARET G Dir Exercise / conversion
M · derivative
Common Stock (right to buy) 5,000 $127.54 $637,700 10,000
2022-03-31 MCGLYNN MARGARET G Dir Open-market sell
S
Common Stock 1,011 $262.97 $265,863 1,099
2022-03-31 MCGLYNN MARGARET G Dir Open-market sell
S
Common Stock 2,970 $262.37 $779,239 2,110
2022-03-31 MCGLYNN MARGARET G Dir Open-market sell
S
Common Stock 1,019 $261.28 $266,244 5,080
2022-03-31 MCGLYNN MARGARET G Dir Exercise / conversion
M
Common Stock 5,000 $127.54 $637,700 6,099
2022-03-17 Tatsis Ourania EVP, Chief Reg. & Quality Off. Open-market sell
S
Common Stock 34 $251.24 $8,542 47,356
2022-03-17 Tatsis Ourania EVP, Chief Reg. & Quality Off. Open-market sell
S
Common Stock 2,799 $250.10 $700,030 47,390
2022-02-24 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 2,189 $227.86 $498,786 49,373
2022-02-17 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 3,439 $232.51 $799,602 51,562
2022-02-14 ALTSHULER DAVID EVP, Global Research and CSO Open-market sell
S
Common Stock 2,444 $232.02 $567,057 57,438
2022-02-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 2,434 $237.74 $578,659 55,001
2022-02-02 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 2,944 $250.07 $736,206 57,435
2022-02-01 WAGNER CHARLES F JR EVP & Chief Financial Officer Equity grant / award
A
Common Stock 10,262 $0.00 $0 60,379
2022-02-01 WAGNER CHARLES F JR EVP & Chief Financial Officer Equity grant / award
A
Common Stock 11,628 $0.00 $0 50,117
2022-02-01 WAGNER CHARLES F JR EVP & Chief Financial Officer Equity grant / award
A
Common Stock 3,698 $0.00 $0 38,489
2022-01-28 MCGLYNN MARGARET G Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 5,000 $127.54 $637,700 15,000
2022-01-28 MCGLYNN MARGARET G Dir Open-market sell
S
Common Stock 212 $243.24 $51,567 1,099
2022-01-28 MCGLYNN MARGARET G Dir Open-market sell
S
Common Stock 2,087 $242.78 $506,682 1,311
2022-01-28 MCGLYNN MARGARET G Dir Open-market sell
S
Common Stock 800 $241.83 $193,464 3,398
2022-01-28 MCGLYNN MARGARET G Dir Open-market sell
S
Common Stock 1,901 $240.53 $457,248 4,198
2022-01-28 MCGLYNN MARGARET G Dir Exercise / conversion
M
Common Stock 5,000 $127.54 $637,700 6,099
2022-01-14 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 190 $230.58 $43,750 13,672
2021-11-15 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 30 $187.48 $5,624 31,928
2021-11-15 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 21 $186.78 $3,922 31,958
2021-11-01 Sanna Bastiano EVP, Cell & Genetic Therapies Other disposed transaction
F
Common Stock 766 $185.07 $141,764 32,576
2021-10-15 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 240 $182.07 $43,750 13,483
2021-08-19 Kewalramani Reshma CEO & President Open-market buy
P
Common Stock 4,243 $196.34 $833,071 73,754
2021-08-19 Kewalramani Reshma CEO & President Open-market buy
P
Common Stock 5,757 $195.14 $1,123,421 69,511
2021-08-02 SACHS BRUCE I Dir Open-market buy
P
Common Stock 15,000 $197.91 $2,968,650 41,210
2021-07-30 Sanna Bastiano EVP, Cell & Genetic Therapies Other disposed transaction
F
Common Stock 766 $200.39 $153,499 33,342
2021-07-15 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 221 $198.00 $43,750 13,242
2021-06-02 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 121 $211.00 $25,531 5,191
2021-06-02 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 153 $210.01 $32,132 5,312
2021-06-02 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 285 $208.96 $59,554 5,465
2021-06-01 MCGLYNN MARGARET G Dir Equity grant / award
A · derivative
Deferred Stock Units 699 4,688
2021-06-01 MCGLYNN MARGARET G Dir Other disposed transaction
D
Common Stock 699 1,099
2021-05-28 Bozic Carmen EVP and CMO Other disposed transaction
F
Common Stock 311 $210.04 $65,322 32,953
2021-05-17 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 47 $216.88 $10,193 34,108
2021-05-17 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 65 $215.95 $14,037 34,155
2021-05-01 SACHS BRUCE I Dir Equity grant / award
A · derivative
Stock Option (Right to Buy) 6,067 $0.00 $0 6,067
2021-04-30 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 547 $217.21 $118,814 34,679
2021-04-27 Sachdev Amit EVP, Chief Patient Officer Exercise / conversion
M · derivative
Stock Option (Right to Buy) 3,884 $0.00 $0 0
2021-04-27 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 200 $217.69 $43,538 40,133
2021-04-27 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 1,338 $216.67 $289,904 40,333
2021-04-27 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 2,346 $215.58 $505,751 41,671
2021-04-27 Sachdev Amit EVP, Chief Patient Officer Exercise / conversion
M
Common Stock 3,884 $86.52 $336,044 44,017
2021-04-15 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 199 $220.17 $43,750 13,021
2021-04-05 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 389 $214.99 $83,631 35,834
2021-04-05 Sanna Bastiano EVP, Cell & Genetic Therapies Open-market sell
S
Common Stock 1,297 $213.89 $277,415 36,223
2021-04-01 Sanna Bastiano EVP, Cell & Genetic Therapies Other disposed transaction
F
Common Stock 1,344 $214.16 $287,831 37,520
2021-03-05 Liu Joy SVP, General Counsel Open-market sell
S
Common Stock 256 $212.28 $54,344 8,253
2021-03-05 Liu Joy SVP, General Counsel Open-market sell
S
Common Stock 1,460 $211.67 $309,038 8,509
2021-03-05 Liu Joy SVP, General Counsel Open-market sell
S
Common Stock 844 $210.64 $177,780 9,969
2021-03-05 Liu Joy SVP, General Counsel Open-market sell
S
Common Stock 111 $209.37 $23,240 10,813
2021-03-05 Liu Joy SVP, General Counsel Open-market sell
S
Common Stock 1,119 $208.39 $233,188 10,924
2021-03-05 Liu Joy SVP, General Counsel Open-market sell
S
Common Stock 1,351 $207.57 $280,427 12,043
2021-03-01 Silva Paul M SVP & Chief Accounting Officer Open-market sell
S
Common Stock 231 $213.12 $49,231 9,884
2021-03-01 Silva Paul M SVP & Chief Accounting Officer Open-market sell
S
Common Stock 915 $212.51 $194,447 10,115
2021-03-01 Silva Paul M SVP & Chief Accounting Officer Open-market sell
S
Common Stock 610 $211.45 $128,984 11,030
2021-03-01 Silva Paul M SVP & Chief Accounting Officer Open-market sell
S
Common Stock 1,026 $210.13 $215,593 11,640
2021-02-26 Silva Paul M SVP & Chief Accounting Officer Other disposed transaction
F
Common Stock 2,218 $212.42 $471,148 12,666
2021-02-24 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 547 $217.57 $119,011 35,226
2021-02-17 Tatsis Ourania EVP, Chief Reg. & Quality Off. Other disposed transaction
F
Common Stock 2,000 $211.75 $423,500 32,468
2021-02-11 Silva Paul M SVP & Chief Accounting Officer Open-market sell
S
Common Stock 210 $211.32 $44,377 23,863
2021-02-11 Silva Paul M SVP & Chief Accounting Officer Open-market sell
S
Common Stock 1,288 $210.45 $271,060 24,073
2021-02-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Other disposed transaction
F
Common Stock 2,365 $214.16 $506,488 35,773
2021-02-05 Parini Michael EVP, Chief Adm, Leg & BD Off Open-market sell
S
Common Stock 1,930 $215.00 $414,950 57,227
2021-02-05 Parini Michael EVP, Chief Adm, Leg & BD Off Exercise / conversion
M · derivative
Common Stock 1,930 $0.00 $0 0
2021-02-03 WAGNER CHARLES F JR EVP & Chief Financial Officer Equity grant / award
A
Common Stock 11,627 $0.00 $0 38,138
2021-02-03 WAGNER CHARLES F JR EVP & Chief Financial Officer Equity grant / award
A
Common Stock 10,324 $0.00 $0 26,511
2021-01-15 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 194 $225.99 $43,750 12,823
2020-11-16 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 8 $224.44 $1,796 35,103
2020-11-16 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 22 $223.76 $4,923 35,111
2020-11-16 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 12 $222.50 $2,670 35,133
2020-11-10 SACHS BRUCE I Dir Open-market buy
P
Common Stock 3,905 $218.79 $854,375 26,210
2020-11-10 SACHS BRUCE I Dir Open-market buy
P
Common Stock 4,270 $217.49 $928,682 22,305
2020-11-10 SACHS BRUCE I Dir Open-market buy
P
Common Stock 6,825 $216.47 $1,477,408 18,035
2020-11-04 Parini Michael EVP, Chief Adm, Leg & BD Off Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,330 $0.00 $0 2,330
2020-11-04 Parini Michael EVP, Chief Adm, Leg & BD Off Open-market sell
S
Common Stock 200 $221.25 $44,250 26,838
2020-11-04 Parini Michael EVP, Chief Adm, Leg & BD Off Open-market sell
S
Common Stock 300 $220.10 $66,030 27,038
2020-11-04 Parini Michael EVP, Chief Adm, Leg & BD Off Open-market sell
S
Common Stock 600 $218.63 $131,178 27,338
2020-11-04 Parini Michael EVP, Chief Adm, Leg & BD Off Open-market sell
S
Common Stock 630 $215.16 $135,551 28,538
2020-11-04 Parini Michael EVP, Chief Adm, Leg & BD Off Exercise / conversion
M
Common Stock 2,330 $86.52 $201,592 29,168
2020-11-03 Arbuckle Stuart A EVP, Chief Commercial Officer Exercise / conversion
M · derivative
Stock Option (Right to Buy) 1,553 $0.00 $0 1,554
2020-11-03 Arbuckle Stuart A EVP, Chief Commercial Officer Open-market sell
S
Common Stock 334 $214.13 $71,519 35,179
2020-11-03 Arbuckle Stuart A EVP, Chief Commercial Officer Open-market sell
S
Common Stock 245 $212.38 $52,033 35,513
2020-11-03 Arbuckle Stuart A EVP, Chief Commercial Officer Open-market sell
S
Common Stock 487 $211.54 $103,020 35,758
2020-11-03 Arbuckle Stuart A EVP, Chief Commercial Officer Exercise / conversion
M
Common Stock 1,553 $86.52 $134,366 36,732
2020-10-15 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 196 $222.81 $43,750 12,629
2020-10-05 Bhatia Sangeeta N. Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 8,729 $0.00 $0 0
2020-10-05 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 2,212 $268.61 $594,165 3,908
2020-10-05 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 2,670 $267.92 $715,346 6,120
2020-10-05 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 2,070 $266.66 $551,986 8,790
2020-10-05 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 1,787 $265.82 $475,020 10,860
2020-10-05 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 892 $264.60 $236,023 12,647
2020-10-05 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 594 $263.54 $156,543 13,539
2020-10-05 Bhatia Sangeeta N. Dir Open-market sell
S
Common Stock 291 $262.66 $76,434 14,133
2020-10-05 Bhatia Sangeeta N. Dir Exercise / conversion
M
Common Stock 8,729 $126.68 $1,105,790 14,424
2020-08-25 MCGLYNN MARGARET G Dir Equity grant / award
G
Common Stock 3,707 $0.00 $0 877
2020-08-06 Silva Paul M SVP & Controller Exercise / conversion
M · derivative
Stock Option (Right to Buy) 612 $0.00 $0 3,669
2020-08-06 Silva Paul M SVP & Controller Exercise / conversion
M · derivative
Stock Option (Right to Buy) 466 $0.00 $0 4,656
2020-08-06 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 74 $272.87 $20,192 14,932
2020-08-06 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 373 $272.15 $101,512 15,006
2020-08-06 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 211 $270.92 $57,164 15,379
2020-08-06 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 420 $270.12 $113,450 15,590
2020-08-06 Silva Paul M SVP & Controller Exercise / conversion
M
Common Stock 612 $155.57 $95,209 16,010
2020-08-06 Silva Paul M SVP & Controller Exercise / conversion
M
Common Stock 466 $187.53 $87,389 15,398
2020-08-03 Sachdev Amit EVP, Chief Patient Officer Exercise / conversion
M · derivative
Stock Option (Right to Buy) 1,941 $0.00 $0 3,884
2020-08-03 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 751 $279.18 $209,664 35,103
2020-08-03 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 690 $278.25 $191,992 35,854
2020-08-03 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 500 $276.96 $138,480 36,544
2020-08-03 Sachdev Amit EVP, Chief Patient Officer Exercise / conversion
M
Common Stock 1,941 $86.52 $167,935 37,044
2020-07-15 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 155 $292.77 $45,453 12,433
2020-07-13 Silva Paul M SVP & Controller Exercise / conversion
M · derivative
Stock Options (Right to Buy) 860 $0.00 $0 0
2020-07-13 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 250 $294.99 $73,748 15,032
2020-07-13 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 200 $294.18 $58,836 15,282
2020-07-13 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 50 $291.97 $14,598 15,482
2020-07-13 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 60 $285.71 $17,143 15,632
2020-07-13 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 100 $295.78 $29,578 14,932
2020-07-13 Silva Paul M SVP & Controller Exercise / conversion
M
Common Stock 860 $90.29 $77,649 15,792
2020-07-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 260 $293.90 $76,414 16,126
2020-07-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 400 $292.86 $117,144 16,386
2020-07-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Open-market sell
S
Common Stock 40 $291.19 $11,648 16,786
2020-07-07 Arbuckle Stuart A EVP, Chief Commercial Officer Exercise / conversion
M · derivative
Stock Option (Right to buy) 1,222 $0.00 $0 8,561
2020-07-07 Arbuckle Stuart A EVP, Chief Commercial Officer Exercise / conversion
M · derivative
Stock Option (Right to buy) 1,564 $0.00 $0 17,206
2020-07-07 Arbuckle Stuart A EVP, Chief Commercial Officer Open-market sell
S
Common Stock 2,786 $300.00 $835,800 35,179
2020-07-07 Arbuckle Stuart A EVP, Chief Commercial Officer Exercise / conversion
M
Common Stock 1,222 $155.57 $190,107 37,965
2020-07-07 Arbuckle Stuart A EVP, Chief Commercial Officer Exercise / conversion
M
Common Stock 1,564 $187.53 $293,297 36,743
2020-06-30 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 200 $291.34 $58,268 2,261
2020-06-30 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 2,534 $290.51 $736,152 2,461
2020-06-30 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 500 $289.39 $144,695 4,995
2020-06-30 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 1,318 $287.91 $379,465 5,495
2020-06-30 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 4,885 $287.23 $1,403,119 6,813
2020-06-30 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 8,321 $286.13 $2,380,888 11,698
2020-06-30 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 9,233 $285.11 $2,632,421 20,019
2020-06-30 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 5,801 $284.14 $1,648,296 29,252
2020-06-03 MCKENZIE DIANA Dir Equity grant / award
A
Common Stock 1,435 $0.00 $0 1,435
2020-06-01 YOUNG WILLIAM D Dir Equity grant / award
A · derivative
Stock Option (Right to Buy) 4,527 $0.00 $0 4,527
2020-05-29 Bozic Carmen EVP and CMO Other disposed transaction
F
Common Stock 311 $282.74 $87,932 13,991
2020-05-15 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 19 $287.63 $5,465 26,635
2020-05-15 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 27 $286.07 $7,724 26,654
2020-05-15 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 10 $283.76 $2,838 26,681
2020-05-15 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 4 $282.74 $1,131 26,691
2020-05-15 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 9 $288.37 $2,595 26,626
2020-05-15 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 7 $279.70 $1,958 26,710
2020-05-15 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 6 $281.74 $1,690 26,695
2020-05-15 Kewalramani Reshma CEO & President Open-market sell
S
Common Stock 2 $274.37 $549 26,723
2020-05-12 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M · derivative
Stock Option (Right to Buy) 24,348 $0.00 $0 0
2020-05-12 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M · derivative
Stock Option (Right to Buy) 4,470 $0.00 $0 93,866
2020-05-12 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M · derivative
Stock Option (Right to Buy) 35,499 $0.00 $0 0
2020-05-12 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M · derivative
Stock Option (Right to Buy) 24,215 $0.00 $0 0
2020-05-12 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 100 $288.42 $28,842 34,983
2020-05-12 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 9,630 $287.81 $2,771,610 35,083
2020-05-12 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 15,792 $286.70 $4,527,566 44,713
2020-05-12 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 8,391 $285.68 $2,397,141 60,505
2020-05-12 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 10,179 $285.06 $2,901,626 68,896
2020-05-12 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 9,219 $283.86 $2,616,905 79,075
2020-05-12 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 9,780 $282.66 $2,764,415 88,294
2020-05-12 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 9,398 $281.83 $2,648,638 98,074
2020-05-12 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 6,498 $280.76 $1,824,378 107,472
2020-05-12 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 1,940 $278.96 $541,182 113,970
2020-05-12 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 4,428 $277.94 $1,230,718 115,910
2020-05-12 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 9,015 $277.14 $2,498,417 120,338
2020-05-12 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M
Common Stock 24,348 $155.57 $3,787,818 129,353
2020-05-12 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M
Common Stock 4,470 $91.05 $406,994 105,005
2020-05-12 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M
Common Stock 35,499 $96.87 $3,438,788 100,535
2020-05-12 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M
Common Stock 24,215 $187.53 $4,541,039 65,036
2020-05-11 Sachdev Amit EVP, Chief Patient Officer Exercise / conversion
M · derivative
Stock Option (Right to Buy) 10,665 $0.00 $0 0
2020-05-11 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 100 $286.72 $28,672 35,103
2020-05-11 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 1,367 $285.94 $390,880 35,203
2020-05-11 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 2,314 $285.15 $659,837 36,570
2020-05-11 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 1,100 $283.98 $312,378 38,884
2020-05-11 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 913 $282.89 $258,279 39,984
2020-05-11 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 1,398 $281.74 $393,873 40,897
2020-05-11 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 1,817 $280.77 $510,159 42,295
2020-05-11 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 655 $279.67 $183,184 44,112
2020-05-11 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 201 $277.38 $55,753 44,767
2020-05-11 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 800 $276.25 $221,000 44,968
2020-05-11 Sachdev Amit EVP, Chief Patient Officer Exercise / conversion
M
Common Stock 10,665 $131.89 $1,406,607 45,768
2020-05-07 SACHS BRUCE I Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 22,500 $0.00 $0 0
2020-05-07 SACHS BRUCE I Dir Open-market sell
S
Common Stock 2,960 $272.46 $806,482 11,210
2020-05-07 SACHS BRUCE I Dir Open-market sell
S
Common Stock 6,232 $271.63 $1,692,798 14,170
2020-05-07 SACHS BRUCE I Dir Open-market sell
S
Common Stock 5,889 $270.49 $1,592,916 20,402
2020-05-07 SACHS BRUCE I Dir Open-market sell
S
Common Stock 15,751 $269.53 $4,245,367 26,291
2020-05-07 SACHS BRUCE I Dir Open-market sell
S
Common Stock 11,568 $268.65 $3,107,743 42,042
2020-05-07 SACHS BRUCE I Dir Open-market sell
S
Common Stock 2,600 $267.50 $695,500 53,610
2020-05-07 SACHS BRUCE I Dir Exercise / conversion
M
Common Stock 22,500 $81.54 $1,834,650 56,210
2020-05-06 Tatsis Ourania EVP, Chief Regulatory Officer Exercise / conversion
M · derivative
Stock Option (Right to Buy) 407 $0.00 $0 2,854
2020-05-06 Tatsis Ourania EVP, Chief Regulatory Officer Exercise / conversion
M · derivative
Stock Option (Right to Buy) 559 $0.00 $0 6,145
2020-05-06 Tatsis Ourania EVP, Chief Regulatory Officer Open-market sell
S
Common Stock 30 $275.30 $8,259 12,738
2020-05-06 Tatsis Ourania EVP, Chief Regulatory Officer Open-market sell
S
Common Stock 330 $274.13 $90,463 12,768
2020-05-06 Tatsis Ourania EVP, Chief Regulatory Officer Open-market sell
S
Common Stock 210 $273.15 $57,362 13,098
2020-05-06 Tatsis Ourania EVP, Chief Regulatory Officer Open-market sell
S
Common Stock 217 $272.09 $59,044 13,308
2020-05-06 Tatsis Ourania EVP, Chief Regulatory Officer Open-market sell
S
Common Stock 136 $270.19 $36,746 13,525
2020-05-06 Tatsis Ourania EVP, Chief Regulatory Officer Open-market sell
S
Common Stock 43 $268.80 $11,558 13,661
2020-05-06 Tatsis Ourania EVP, Chief Regulatory Officer Exercise / conversion
M
Common Stock 407 $155.57 $63,317 13,704
2020-05-06 Tatsis Ourania EVP, Chief Regulatory Officer Exercise / conversion
M
Common Stock 559 $187.53 $104,829 13,297
2020-05-05 Sachdev Amit EVP, Chief Patient Officer Exercise / conversion
M · derivative
Stock Option (Right to Buy) 13,356 $0.00 $0 11,334
2020-05-05 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 200 $273.59 $54,718 35,103
2020-05-05 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 403 $272.58 $109,850 35,303
2020-05-05 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 11,553 $270.01 $3,119,426 35,806
2020-05-05 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 700 $269.08 $188,356 47,359
2020-05-05 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 300 $267.34 $80,202 48,059
2020-05-05 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 100 $271.09 $27,109 35,706
2020-05-05 Sachdev Amit EVP, Chief Patient Officer Exercise / conversion
M
Common Stock 13,356 $131.89 $1,761,523 48,459
2020-05-05 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M · derivative
Stock Option (Right to Buy) 24,349 $0.00 $0 48,697
2020-05-05 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M · derivative
Stock Option (Right to Buy) 4,470 $0.00 $0 102,806
2020-05-05 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M · derivative
Stock Option (Right to Buy) 35,502 $0.00 $0 70,998
2020-05-05 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M · derivative
Stock Option (Right to Buy) 24,216 $0.00 $0 48,431
2020-05-05 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 5,375 $273.70 $1,471,138 46,656
2020-05-05 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 12,849 $272.97 $3,507,392 52,031
2020-05-05 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 11,832 $272.12 $3,219,724 64,880
2020-05-05 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 6,003 $270.86 $1,625,973 76,712
2020-05-05 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 15,681 $269.56 $4,226,970 82,715
2020-05-05 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 22,613 $268.86 $6,079,731 98,396
2020-05-05 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 10,878 $267.62 $2,911,170 121,009
2020-05-05 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 4,921 $266.66 $1,312,234 131,887
2020-05-05 LEIDEN JEFFREY M Executive Chairman Open-market sell
S
Common Stock 4,220 $265.57 $1,120,705 136,808
2020-05-05 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M
Common Stock 24,349 $155.57 $3,787,974 141,028
2020-05-05 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M
Common Stock 4,470 $91.05 $406,994 116,679
2020-05-05 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M
Common Stock 35,502 $96.87 $3,439,079 112,209
2020-05-05 LEIDEN JEFFREY M Executive Chairman Exercise / conversion
M
Common Stock 24,216 $187.53 $4,541,226 76,707
2020-05-04 Sachdev Amit EVP, Chief Patient Officer Exercise / conversion
M · derivative
Stock Option (Right to Buy) 1,942 $0.00 $0 5,825
2020-05-04 Sachdev Amit EVP, Chief Patient Officer Exercise / conversion
M · derivative
Stock Option (Right to Buy) 9,310 $0.00 $0 24,690
2020-05-04 Sachdev Amit EVP, Chief Patient Officer Exercise / conversion
M · derivative
Stock Option (Right to Buy) 32,500 $0.00 $0 0
2020-05-04 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 12,940 $264.92 $3,428,065 35,103
2020-05-04 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 964 $263.58 $254,091 48,043
2020-05-04 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 9,447 $262.69 $2,481,632 49,007
2020-05-04 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 4,395 $261.68 $1,150,084 58,454
2020-05-04 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 8,383 $260.48 $2,183,604 62,849
2020-05-04 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 6,223 $259.63 $1,615,677 71,232
2020-05-04 Sachdev Amit EVP, Chief Patient Officer Open-market sell
S
Common Stock 1,400 $258.59 $362,026 77,455
2020-05-04 Sachdev Amit EVP, Chief Patient Officer Exercise / conversion
M
Common Stock 1,942 $86.52 $168,022 78,855
2020-05-04 Sachdev Amit EVP, Chief Patient Officer Exercise / conversion
M
Common Stock 9,310 $131.89 $1,227,896 76,913
2020-05-04 Sachdev Amit EVP, Chief Patient Officer Exercise / conversion
M
Common Stock 32,500 $109.14 $3,547,050 67,603
2020-04-30 WAGNER CHARLES F JR EVP and CFO Other disposed transaction
F
Common Stock 547 $251.78 $137,724 16,727
2020-04-29 Parini Michael EVP, Chief Adm, Leg & BD Off Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,125 $0.00 $0 2,125
2020-04-29 Parini Michael EVP, Chief Adm, Leg & BD Off Open-market sell
S
Common Stock 100 $258.15 $25,815 26,838
2020-04-29 Parini Michael EVP, Chief Adm, Leg & BD Off Open-market sell
S
Common Stock 500 $256.63 $128,315 26,938
2020-04-29 Parini Michael EVP, Chief Adm, Leg & BD Off Open-market sell
S
Common Stock 680 $255.44 $173,699 27,438
2020-04-29 Parini Michael EVP, Chief Adm, Leg & BD Off Open-market sell
S
Common Stock 400 $254.20 $101,680 28,118
2020-04-29 Parini Michael EVP, Chief Adm, Leg & BD Off Open-market sell
S
Common Stock 300 $252.70 $75,810 28,518
2020-04-29 Parini Michael EVP, Chief Adm, Leg & BD Off Open-market sell
S
Common Stock 145 $251.38 $36,450 28,818
2020-04-29 Parini Michael EVP, Chief Adm, Leg & BD Off Exercise / conversion
M
Common Stock 2,125 $90.29 $191,866 28,963
2020-04-28 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 1,125 $0.00 $0 0
2020-04-28 Lee Yuchun Dir Open-market sell
S
Common Stock 116 $261.80 $30,369 1,875
2020-04-28 Lee Yuchun Dir Open-market sell
S
Common Stock 180 $260.53 $46,895 1,991
2020-04-28 Lee Yuchun Dir Open-market sell
S
Common Stock 120 $259.61 $31,153 2,171
2020-04-28 Lee Yuchun Dir Open-market sell
S
Common Stock 149 $257.20 $38,323 2,411
2020-04-28 Lee Yuchun Dir Open-market sell
S
Common Stock 240 $255.79 $61,390 2,560
2020-04-28 Lee Yuchun Dir Open-market sell
S
Common Stock 200 $254.81 $50,962 2,800
2020-04-28 Lee Yuchun Dir Exercise / conversion
M
Common Stock 1,125 $57.27 $64,429 3,000
2020-04-27 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 1,125
2020-04-27 Lee Yuchun Dir Open-market sell
S
Common Stock 100 $273.44 $27,344 1,875
2020-04-27 Lee Yuchun Dir Open-market sell
S
Common Stock 200 $272.51 $54,502 1,975
2020-04-27 Lee Yuchun Dir Open-market sell
S
Common Stock 1,113 $271.56 $302,246 2,175
2020-04-27 Lee Yuchun Dir Open-market sell
S
Common Stock 394 $270.37 $106,526 3,288
2020-04-27 Lee Yuchun Dir Open-market sell
S
Common Stock 193 $268.40 $51,801 3,682
2020-04-27 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $57.27 $114,540 3,875
2020-04-24 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 3,125
2020-04-24 Lee Yuchun Dir Open-market sell
S
Common Stock 120 $270.30 $32,436 1,875
2020-04-24 Lee Yuchun Dir Open-market sell
S
Common Stock 400 $269.28 $107,712 1,995
2020-04-24 Lee Yuchun Dir Open-market sell
S
Common Stock 590 $268.31 $158,303 2,395
2020-04-24 Lee Yuchun Dir Open-market sell
S
Common Stock 890 $267.23 $237,835 2,985
2020-04-24 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $57.27 $114,540 3,875
2020-04-23 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 5,125
2020-04-23 Lee Yuchun Dir Open-market sell
S
Common Stock 47 $276.45 $12,993 1,875
2020-04-23 Lee Yuchun Dir Open-market sell
S
Common Stock 600 $275.90 $165,540 1,922
2020-04-23 Lee Yuchun Dir Open-market sell
S
Common Stock 400 $274.23 $109,692 2,522
2020-04-23 Lee Yuchun Dir Open-market sell
S
Common Stock 100 $272.55 $27,255 2,922
2020-04-23 Lee Yuchun Dir Open-market sell
S
Common Stock 300 $271.03 $81,309 3,022
2020-04-23 Lee Yuchun Dir Open-market sell
S
Common Stock 200 $269.23 $53,846 3,322
2020-04-23 Lee Yuchun Dir Open-market sell
S
Common Stock 353 $267.47 $94,417 3,522
2020-04-23 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $57.27 $114,540 3,875
2020-04-22 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 7,125
2020-04-22 Lee Yuchun Dir Open-market sell
S
Common Stock 369 $270.54 $99,829 1,875
2020-04-22 Lee Yuchun Dir Open-market sell
S
Common Stock 224 $268.48 $60,140 2,544
2020-04-22 Lee Yuchun Dir Open-market sell
S
Common Stock 507 $267.34 $135,541 2,768
2020-04-22 Lee Yuchun Dir Open-market sell
S
Common Stock 300 $269.47 $80,841 2,244
2020-04-22 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $57.27 $114,540 3,875
2020-04-21 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 9,125
2020-04-21 Lee Yuchun Dir Open-market sell
S
Common Stock 100 $272.63 $27,263 1,875
2020-04-21 Lee Yuchun Dir Open-market sell
S
Common Stock 403 $267.15 $107,661 2,375
2020-04-21 Lee Yuchun Dir Open-market sell
S
Common Stock 300 $271.38 $81,414 1,975
2020-04-21 Lee Yuchun Dir Open-market sell
S
Common Stock 500 $264.80 $132,400 3,078
2020-04-21 Lee Yuchun Dir Open-market sell
S
Common Stock 297 $263.20 $78,170 3,578
2020-04-21 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $57.27 $114,540 3,875
2020-04-20 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 11,125
2020-04-20 Lee Yuchun Dir Open-market sell
S
Common Stock 500 $274.65 $137,325 1,875
2020-04-20 Lee Yuchun Dir Open-market sell
S
Common Stock 890 $273.61 $243,513 2,375
2020-04-20 Lee Yuchun Dir Open-market sell
S
Common Stock 510 $271.52 $138,475 3,265
2020-04-20 Lee Yuchun Dir Open-market sell
S
Common Stock 100 $269.97 $26,997 3,775
2020-04-20 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $57.27 $114,540 3,875
2020-04-15 SACHS BRUCE I Dir Equity grant / award
A · derivative
Deferred Stock Units 179 $258.56 $46,250 12,277
2020-04-13 Silva Paul M SVP & Controller Exercise / conversion
M · derivative
Stock Option (Right to Buy) 859 $0.00 $0 860
2020-04-13 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 166 $252.26 $41,875 14,932
2020-04-13 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 193 $250.29 $48,306 15,098
2020-04-13 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 150 $248.96 $37,344 15,291
2020-04-13 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 50 $244.09 $12,204 15,741
2020-04-13 Silva Paul M SVP & Controller Exercise / conversion
M
Common Stock 859 $90.29 $77,559 15,791
2020-04-06 Silva Paul M SVP & Controller Exercise / conversion
M · derivative
Stock Option (Right to Buy) 4,891 $0.00 $0 4,892
2020-04-06 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 4,891 $255.57 $1,249,993 14,932
2020-04-06 Silva Paul M SVP & Controller Exercise / conversion
M
Common Stock 4,891 $155.57 $760,893 19,823
2020-03-31 LEIDEN JEFFREY M Executive Chairman Other disposed transaction
F
Common Stock 40,090 $234.01 $9,381,461 52,491
2020-02-24 WAGNER CHARLES F JR EVP and CFO Other disposed transaction
F
Common Stock 542 $239.23 $129,663 17,274
2020-02-18 Tatsis Ourania SVP, CRO Open-market sell
S
Common Stock 145 $245.75 $35,634 15,070
2020-02-18 Tatsis Ourania SVP, CRO Open-market sell
S
Common Stock 286 $244.99 $70,067 15,215
2020-02-18 Tatsis Ourania SVP, CRO Open-market sell
S
Common Stock 528 $242.78 $128,188 15,661
2020-02-18 Tatsis Ourania SVP, CRO Open-market sell
S
Common Stock 160 $243.78 $39,005 15,501
2020-02-17 Tatsis Ourania SVP, CRO Other disposed transaction
F
Common Stock 597 $241.50 $144,176 16,349
2020-02-11 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 1,102 $247.93 $273,219 19,688
2020-02-11 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 1,120 $246.84 $276,461 20,790
2020-02-11 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 1,700 $245.89 $418,013 21,910
2020-02-11 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 1,560 $244.90 $382,044 23,610
2020-02-11 Silva Paul M SVP & Controller Open-market sell
S
Common Stock 380 $243.59 $92,564 25,170
2020-02-10 Silva Paul M SVP & Controller Other disposed transaction
F
Common Stock 4,673 $240.95 $1,125,959 25,550
2020-02-07 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 14,306
2020-02-07 Lee Yuchun Dir Open-market sell
S
Common Stock 600 $239.96 $143,976 1,875
2020-02-07 Lee Yuchun Dir Open-market sell
S
Common Stock 700 $237.51 $166,257 2,675
2020-02-07 Lee Yuchun Dir Open-market sell
S
Common Stock 200 $238.50 $47,700 2,475
2020-02-07 Lee Yuchun Dir Open-market sell
S
Common Stock 300 $234.84 $70,452 3,575
2020-02-07 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $57.27 $114,540 3,875
2020-02-06 Lee Yuchun Dir Exercise / conversion
M · derivative
Stock Option (Right to Buy) 2,000 $0.00 $0 16,306
2020-02-06 Lee Yuchun Dir Open-market sell
S
Common Stock 100 $244.08 $24,408 1,875
2020-02-06 Lee Yuchun Dir Open-market sell
S
Common Stock 429 $240.65 $103,239 1,975
2020-02-06 Lee Yuchun Dir Open-market sell
S
Common Stock 400 $239.28 $95,712 2,404
2020-02-06 Lee Yuchun Dir Open-market sell
S
Common Stock 1,071 $238.71 $255,658 2,804
2020-02-06 Lee Yuchun Dir Exercise / conversion
M
Common Stock 2,000 $57.27 $114,540 3,875
2020-02-05 WAGNER CHARLES F JR EVP and CFO Equity grant / award
A
Common Stock 10,323 $0.00 $0 17,816
2020-02-05 WAGNER CHARLES F JR EVP and CFO Equity grant / award
A
Common Stock 3,698 $0.00 $0 7,493
2020-02-05 LEIDEN JEFFREY M CEO & President Equity grant / award
A
Common Stock 31,462 $0.00 $0 216,818
2020-02-05 LEIDEN JEFFREY M CEO & President Equity grant / award
A
Common Stock 28,444 $0.00 $0 185,356
2020-02-05 LEIDEN JEFFREY M CEO & President Equity grant / award
A
Common Stock 50,566 $0.00 $0 156,912

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
33
Material Event Filings (8-K) — 12 months
7

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.